The CAA is actively funding significant research studies that have attracted additional funding from other sources. The CAA educates patients and professionals via webinars. It has established a BioBank to provide a consistent data base for future studies, including XMRV. Kim McCleary, the staff and the BOD (all volunteer, elected and not appointed) are very dedicated and all work extremely hard. Previous comments suggest there is room for improvement. What specific changes are you suggesting?
Using Leonard Jason's estimates, there are roughly 800,000 to 1 million ME/CFS sufferers in the US who meet the conservative Canadian Consensus Diagnostic criteria. The US prevalence of MS is approximately 250,000.
There are nearly four times the number of ME/CFS patients meeting the Canadian Consensus Dx Criteria than there are MS patients in the US.
And yet the funding for ME/CFS research has boarded on (actually has been at times) criminally negligent. Some significant portion of this is due to the efforts of the CDC and NIH to marginalize CFS. These organizations accomplished these goals in the face of a deafening silence amongst an abused, fractured and battered ME/CFS patient population.
Rather than acting as a unifying agent, the CAA has actually been a source of sharp divisions and much contention in the ME/CFS community. For several years, the CAA placed a premium on working with the very organizations that were marginalizing ME/CFS patients and who have consistently and dramatically reduced funding for research. I am well aware of the good intentions of the CAA but the bottom line is that in many ways, these were failed policies. If you look at funding alone, I have difficulty coming to any conclusion other than the CAA policies have had little impact outside of their Biobank and the small number of projects they fund directly.
It is time to reassess. If the CAA had focused on the needs of the ME/CFS patient population and been more patient centered and less "top down," could the CDC and NIH have succeeded in marginalizing and fracturing a united front of advocacy organizations and patients? The CAA's entire current budget is between one and two dollars a patient. I know from my own experience that many times in the past I hesitated to donate as I did not feel that the CAA was representing me. After watching events unfold over the last year, I find it impossible to conclude that most ME/CFS patients, their families and their friends are indifferent to the point of refusing to contribute to an advocacy org. Patients and their families are aching for an organization they can get behind without reservation ("Does this group really represent me or at some point down the road will I find myself having to counter material that I paid for the to distribute to my doctor?").
The disconnect between ME/CFS patients and the CAA is not something that will simply heal itself and that until the CAA connects solidly with their constituents, they will forever under perform (as an organization, not as individuals) do to a lack of support and stable funding for their research efforts.
I am a strong supporter of the CAA as an effective organization to seed promising research and I especially appreciate their efforts to identify a biomarker.
Concerning research, the present mess that is the cohort question in ME/CFS continues to be a source of confusion and a tool of obfuscation for researchers holding a range of preconceptions surrounding ME/CFS patients. Clarifying the cohort question should have been and remained a top priority from the day the organization was created. It is outrageous that we are still arguing semantics and definitions after 25 years. Someone needed to step up and make a stand against what they knew was wrong at the time. The CAA should be at to forefront of these efforts today and yet I see interest, not leadership.
Another area in need of attention is that of disability support. Efforts to identify a biomarker are needed but a biomarker alone does very little to put food on the table or provide housing for those amongst us with the greatest need. Given the small size of the CAA, I know they can't do everything. I just don't think that after 25 years the small size of the CAA was a foregone conclusion.
We are not weak, and we are not uneducated. We are divided, frustrated and often too wounded to feel like the effort is worth the cost when we are not working together.
To be direct, the CAA has managed to find itself alienated from its deepest and potentially most devoted supporters. Strength in advocacy is found in numbers.
From the outside (which is the perspective from which most of see the CAA), the problem appears to be a failure to connect with (even alienation of) those they purport to represent and a "go it alone" style that makes their job much harder than it has to be and at the same time limits the magnitude of the CAA's can accomplish. This has not been the result of a failure of effort or dedication. From my perspective, it appears to be a lack of vision, focus and leadership.
Hundreds of millions, if not billions, of dollars are donated every year to MS charity and advocacy organizations. With four times the number of seriously ill patients, an annual budget of less than 2 million dollars for CFS's (by which definition?) largest advocacy organization is nothing less than heart breaking and it is clearly not acceptable.